UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington D. C. 20549

                                   FORM 10-QSB

(X)  Quarterly  report  pursuant  to Section 13 or 15(d) of the  Securities  and
Exchange Act of 1934.

                     For the quarterly period ended December 31, 2000.

( )  Transition  report  pursuant to Section 13 or 15(d) of the Exchange Act for
the transition period from ____________ to ____________ .


                         Commission File Number: 0-9735

                                  CDX.COM, INC.
                                  -------------
               (Exact name of registrant as specified in charter)

          Colorado                                   84-0771180
(State of Incorporation)                            (I.R.S.Employer I.D. No)

             4200 Wisconsin Avenue NW, 4th Floor, Washington DC 20016
                    (Address of Principal Executive Offices)

                                 (202) 537-7750
                                 --------------
              (Registrant's Telephone Number, Including Area Code)



Check whether the registrant:  (1) has filed all reports required to be filed by
Section by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days.

                                YES ( X ) NO ( )

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
stock as of January 31, 2001.

                    40,000,000 Common Shares, $.01 par value

Transitional Small Business Disclosure Format:

                                 YES ( ) NO (X)



                                       1
<PAGE>




                                  CDX.COM, INC.

                              INDEX TO FORM 10-QSB

PART I.    FINANCIAL INFORMATION

Item 1.    Financial Statements (unaudited)

           Balance Sheets as of December 31, 2000..............................4

           Statements of Operations for the three and six months ended
           December 31, 2000 and 1999..........................................5

           Statements of Cash Flows for the six months ended December 31,
           2000 and 1999.......................................................6

           Notes to Financial Statements.......................................7

Item 2.    Management's Discussion and Analysis of Financial Condition and
           Results of Operation................................................9


PART II.   OTHER INFORMATION

Item 1.    Legal Proceedings..................................................11
Item 2.    Changes in Securities..............................................11
Item 3.    Defaults Upon Senior Securities....................................11
Item 4.    Submission of Matters to a Vote of Securities Holders..............11
Item 5.    Other Information..................................................11
Item 6.    Exhibits and Reports on Form 8-K...................................11

Signatures



                                       2
<PAGE>








                                  CDX.COM, INC.
                           (Formerly CDX Corporation)

                     BALANCE SHEET AS OF DECEMBER 31, 2000,
                            STATEMENTS OF OPERATIONS,
           FOR THE SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999 AND THE
                  THREE MONTHS ENDED DECEMBER 31, 2000 AND 1999
                                       AND
         CASH FLOWS FOR THE SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999



                                       3
<PAGE>







                                  CDX.COM, INC.

                                  BALANCE SHEET
                                   (UNAUDITED)
                                December 31, 2000





                                     ASSETS

      TOTAL ASSETS                                              $            0
                                                                ==============




                    LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current liabilities:
  Accounts payable - trade                                      $       20,275
  Due to the Schein Group                                              568,953
  Due to Tampa Bay Financial, Inc                                        2,837
                                                                --------------
      Total current liabilities                                 $      592,065
                                                                ==============

Stockholders' deficiency:
 Common stock, $.01 par value; 10,000,000 shares authorized,
 4,888,093 shares issued                                                48,881
 Capital surplus                                                     4,771,798
 Deficit                                                            (5,412,744)
 Less:  treasury stock, 166 shares, no assigned value                        -
                                                                --------------
      Total stockholders' deficiency                                  (592,065)
                                                                --------------

      TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY            $            0
                                                                ==============



SEE NOTES TO FINANCIAL STATEMENTS.




                                       4
<PAGE>



                                  CDX.COM, INC.

                            STATEMENTS OF OPERATIONS
                                   (UNAUDITED)
                   SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999
                                       and
                  THREE MONTHS ENDED DECEMBER 31, 2000 AND 1999

<TABLE>
<CAPTION>


                                                July 1, 2000-     July 1, 1999-     October 1, 2000-    October 1, 1999-
                                                 December 31,      December 31,       December 31,        December 31,
                                                     2000             1999                2000                1999
                                                -------------     -------------     ----------------    ----------------
<S>                                             <C>               <C>               <C>                 <C>
Revenues:
  Net sales and other revenues                   $  81,091           $ 105,505          $   32,318         $   46,400
                                                -------------     -------------     ----------------    ----------------
Operating costs and expenses:
  Cost of sales                                     36,198              42,057              14,550             19,154
  Selling & administrative expenses                 63,795              76,093              36,592             39,977
                                                -------------     -------------     ----------------    ----------------
      Total operating costs and expenses            99,993             118,150              51,142             59,131
                                                -------------     -------------     ----------------    ----------------

Operating loss                                     (18,902)            (12,645)            (18,824)           (12,731)
                                                -------------     -------------     ----------------    ----------------
Other expense:
  Interest expense                                  (6,057)            (10,826)                  0             (5,413)
                                                -------------     -------------     ----------------    ----------------

Net loss before extraordinary items                (24,959)            (23,471)            (18,824)           (18,144)

Extraordinary items:
  Gain on transfer of assets and assumption of
  liabilities by Cyber Diagnostics Medical, Inc.   549,909                   0                   0                  0
  Past services rendered by the Schein Group      (568,953)
                                                -------------     -------------     ----------------    ----------------
      Net loss                                   $ (44,003)          $ (23,471)         $  (18,824)        $  (18,144)
                                                =============     =============     ================    ================

Net loss per common share                        $   (.009)          $   (.005)         $    (.004)        $    (.004)
                                                =============     =============     ================    ================

Weighted-average number of common shares
  outstanding                                    4,887,927           4,887,927           4,887,927          4,887,927
                                                =============     =============     ================    ================

After the January 23, 2001 2.33 for 1 stock
dividend:
  Net income (loss) per common share           $     (.004)       $      (.002)       $      (.002)      $      (.002)
                                                -------------     -------------     ----------------    ----------------

  Weighted average number of common shares
  outstanding                                   11,388,870          11,388,870          11,388,870         11,388,870
                                                =============     =============     ================    ================
</TABLE>

SEE NOTES TO FINANCIAL STATEMENTS.




                                       5
<PAGE>




                                  CDX.COM, INC.

                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)
                   SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999



                                                       2000               1999
                                                   ----------         ----------
Cash was provided by (used for):
  Operating activities:
  Net loss                                         $ (44,003)          $(23,471)
  Adjustments to reconcile net income to net
  cash used for operating activities:
    Depreciation and amortization                      7,954             11,204
    Accounts receivable                                                  17,351
  Increase (decrease) in cash from changes in
  assets and liabilities:
    Inventory                                                           (16,927)
    Other assets                                           0                  0
    Accounts payable - trade                                              2,370
    Due to the Schein Group                          568,953
    Accrued interest payable                                             10,827
    Other current liabilities                                              (614)
                                                   ----------         ----------
      Total cash provided by operating
      activities                                     532,904                740
                                                   ----------         ----------

Financing activities:
  Payments on notes payable - officers                                   (6,792)
  Non-cash gain from transfer of assets and
  assumption of liabilities by Cyber
  Diagnostics Medical, Inc                          (549,909)                 0
  Non-cash divestiture of assets and liabilities      (5,129)                 0
                                                   ----------         ----------
      Total cash provided by (used for)
      financing activities                          (555,038)            (6,792)
                                                   ----------         ----------

Decrease in cash during the period                   (22,134)            (6,052)

Cash balance, beginning of the period                 22,134             10,259
                                                   ----------         ----------

Cash balance, end of the period                    $       0           $  4,207
                                                   ==========         ==========

Supplemental disclosures of cash flow information:

  Cash paid during the six months for interest     $       0           $      0
                                                   ==========         ==========


SEE NOTES TO FINANCIAL STATEMENTS.



                                       6
<PAGE>





                                  CDX.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS
                                   (UNAUDITED)
                   SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999



1.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     Background

            CDX.COM,  Inc.  (the  "Company"),  (formerly CDX  Corporation),  was
      incorporated  as a  Colorado  Corporation  in June,  1978 to engage in the
      manufacture and sale of computerized  pulmonary  diagnostic equipment used
      in the medical profession.

            On  November  18,  2000,  Tampa  Bay  Financial,   Inc.,  a  Florida
      Corporation ("TBF"),  entered into an agreement (the "Agreement") with the
      Company and certain of its  stockholders.  The  Agreement  obliged TBF and
      persons  affiliated  with TBF to  acquire  3,523,733  shares  (72%) of the
      Company's  outstanding  common  stock,  thereby  acquiring  control of the
      Company.  The selling  stockholders in the transaction  were the Company's
      directors,  Harold I.  Schein,  Philip D. Schein and  Michael  Schein (the
      "Schein Group").  In addition,  as compensation for services,  the Company
      agreed  to issue  7,111,906  shares of common  stock to the  Schein  Group
      pursuant to a registration  statement on Form S-8. The Schein Group agreed
      after that  issuance to transfer  6,511,906  additional  shares to TBF and
      persons affiliated with TBF.

            Under the agreement, TBF paid aggregate consideration of $262,500 to
      the  Schein  Group.  TBF  changed  the  Company's  business  plan from the
      manufacture and sale of  computerized  pulmonary  diagnostic  equipment to
      international communications.

          In connection with the transaction, the Schein Group resigned from any
     and all positions with the Company,  including  their positions as officers
     and  directors.  Two  designees of TBF, O. Howard  Davidsmeyer  and Matthew
     Veal, were appointed to the Board. In addition, Mr. Davidsmeyer was elected
     to serve as Chairman of the Board and Chief Executive Officer, and Mr. Veal
     was elected to serve as Secretary,  Treasurer and Chief Financial  Officer.
     In December 2000, Mr.  Davidsmeyer  resigned as Chief Executive Officer and
     was replaced by Mr. Philip Verruto,  and Mr. Veal resigned as Treasurer and
     Chief Financial Officer and was replaced by Mr. Craig Thompson.

          On  November  21,  2000,   the  Company   executed  a  contract   with
     Cyberdiagnostics,  Inc.  ("CDI") for the sale of  substantially  all of the
     Company's assets used in connection with the sale of computerized pulmonary
     diagnostic  equipment and  bio-hazard  control  products.  The  transferred
     assets  included all  furniture,  fixtures,  equipment,  inventory,  plans,
     permits,  licenses,  approvals and trade names (including "CDX", "CDX Spiro
     850",  "CDX 50",  "CDX  Biosponse",  and "CDX  Biopail") in addition to the
     Company's books, records signage and goodwill, associated with that line of
     business.

            In  consideration  for the sale,  CDI  expressly  assumed all of the
      Company's  liabilities  and agreed to  indemnify  the Company  against all
      costs,  expenses,  claims,  judgments  or  damages  arising  out of  CDI's
      assumption of liabilities.

      Use of Estimates

            The preparation of financial statements in conformity with generally
      accepted  accounting  principles requires management to make estimates and
      assumptions that affect the reported amounts of assets and liabilities and
      disclosure  of  contingent  assets  and  liabilities  at the  date  of the
      financial  statements  and the  reported  amounts of revenues and expenses
      during the  reporting  period.  Actual  results  could  differ  from those
      estimates.

                                                                     (CONTINUED)


                                       7
<PAGE>



                                  CDX.COM, INC.

                          NOTES TO FINANCIAL STATEMENTS
                                   (UNAUDITED)
                   SIX MONTHS ENDED DECEMBER 31, 2000 AND 1999



1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

      Basis of Presentation

            The accompanying  unaudited financial statements of the Company have
      been prepared in accordance with generally accepted accounting  principles
      for interim financial  information and the instructions to Form 10-QSB and
      Rule 10-1 of Regulation S-X of the Securities and Exchange Commission (the
      "SEC"). Accordingly,  these financial statements do not include all of the
      footnotes required by generally  accepted  accounting  principles.  In the
      opinion of management, all adjustments (consisting of normal and recurring
      adjustments)  considered  necessary  for a  fair  presentation  have  been
      included.  Operating  results for the six and three months ended  December
      31,  2000  are not  necessarily  indicative  of the  results  that  may be
      expected  for the year ended June 30,  2001.  The  accompanying  financial
      statements and the notes should be read in conjunction  with the Company's
      audited  financial  statements  as of June 30, 2000  contained in its Form
      10-KSB.

2.    GOING CONCERN

            The accompanying  financial statements have been prepared on a going
      concern  basis,  which  contemplates  the  realization  of assets  and the
      satisfaction of liabilities in the normal course of business.  The Company
      has a working capital deficiency of $(592,065),  an accumulated deficit of
      $(5,412,744)  as of December 31,  2000,  and a net loss for the six months
      then ended of  $(44,003).  Accordingly  its ability to continue as a going
      concern is dependent on obtaining  capital and  financing  for its planned
      principal  operations.  The  Company  plans to  secure  financing  for its
      ongoing  operations  through  the sale of its common  stock in one or more
      private  placements  and through  issuance of debt.  There is no assurance
      that it will be successful in its efforts to raise capital or secure other
      financing.

3.    SUBSEQUENT EVENTS

            On  January  5,  2001,   the  Company   amended   its   articles  of
      incorporation by substituting the authorization for 500,000,000  shares of
      common stock for the 10,000,000 shares, which were previously authorized.

            On  January 5, 2001,  the Board of  Directors  approved a 2.33 for 1
      stock dividend with a record date of January 23, 2001. The payment date of
      the stock  dividend  was January 24, 2001.  All record  owners of CDX.COM,
      Inc. stock at the close of the market on January 23, 2001 were entitled to
      the additional shares from the stock dividend.

            On January  12,  2001,  a plan of  reorganization  was adopted to be
      effective  January 26, 2001. At the effective time,  PENSAT  International
      Communications,  Inc. merged with and into PENSAT, which was designated as
      the surviving  Corporation,  as a wholly owned subsidiary of CDX.COM, Inc.
      The merger was accounted for as a reverse merger under generally  accepted
      accounting   principles  wherein  PENSAT  stockholders  retained  majority
      interest in the surviving entity. The effect of these transactions will be
      reflected in the Company's financial statements for the period ended March
      31, 2001.





                                       8
<PAGE>



Part I

Item 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATION

OVERVIEW

The following  discussion and analysis  should be read in  conjunction  with the
balance sheet as of December 31, 2000 and the financial statements as of and for
the three and six months  ended  December 31, 2000 and 1999  included  with this
Form 10-QSB.

The Company is currently in the process of creating strategic  relationships and
acquiring  complementary  operating  companies within the global  communications
industry.

Readers   are   referred   to  the   cautionary   statement,   which   addresses
forward-looking statements made by the Company.

RESULTS OF HISTORICAL OPERATIONS

Quarter Ended December 31, 2000 and 1999

For the quarter  ended  December  31, 2000  revenues  were  $32,318  compared to
$46,400 for the quarter ended December 31, 1999

We incurred a net loss of  approximately  $18,824 for the quarter ended December
31, 2000 as compared with a net loss of $18,144 for the quarter  ended  December
31, 1999.  Our  operating  expenses  consist  primarily of sales and general and
administrative  expenses.  General  and  administrative  expenses  decreased  to
$36,592 for the quarter  ended  December  31, 2000 from  $39,977 for the quarter
ended December 31, 1999,  and  principally  includes  payroll and related taxes;
professional fees for consulting, advertising and amortization charges.

The  results of  operations  for the  quarter  ended  December  31, 2000 are not
necessarily  indicative of the results for any future  interim period or for the
year ending June 30, 2001.

Six Months Ended December 31, 2000 and 1999

For  the  six  months  ended   December  31,  2000  we  generated   revenues  of
approximately  $81,091.  We  generated  revenues of $105,505  for the six months
ended December 31, 1999.

We  incurred  a net  loss of  approximately  $44,003  for  the six  months-ended
December  31,  2000  as  compared  with  a net  loss  of  $23,471  for  the  six
months-ended  December 31, 1999.  Our operating  expenses  consist  primarily of
sales and  general  and  administrative  expenses.  General  and  administrative
expenses  decreased to $63,795 for the six months  ended  December 31, 2000 from
$76,093 for the six months ended  December 31, 1999,  and  principally  includes
payroll and related taxes;  professional  fees for  consulting,  advertising and
amortization charges

The results of  operations  for the six months  ended  December 31, 2000 are not
necessarily  indicative of the results for any future  interim period or for the
year ending June 30, 2001.

Liquidity and Capital Resources

Our  operating  requirements  have  exceeded our cash flow from  operations.  At
December 31, 2000 we had cash and cash equivalents of $0.

We will require  additional  capitalization to support and expand our operations
and finance our future working capital requirements.  There can be no assurances
that future capital will become available when needed, or at all.


                                       9
<PAGE>


Future Operations

The  preceding  discussion  of  results  of  operations  relates  to our  former
structure as a medical technology enterprise.  Because of our decision to divest
ourselves  of  all  operations  pertaining  to  that  business,  the  historical
information  presented  is no longer  indicative  of present  or planned  future
operations.  We are now  repositioning  ourselves  as a Global  ICP  (Integrated
Communications Provider) serving the Hispanic and Arabic speaking communities in
America, Latin America, Europe and the Middle East.

CAUTIONARY STATEMENT

This Form 10-QSB, press releases and certain information  provided  periodically
in writing or orally by the Company's  officers or its agents contain statements
which constitute forward-looking statements within the meaning of Section 27A of
the Securities Act, as amended and Section 21E of the Securities Exchange Act of
1934. The words expect,  anticipate,  believe, goal, plan, intend,  estimate and
similar  expressions and variations thereof if used are intended to specifically
identify  forward-looking  statements.  Those  statements  appear in a number of
places in this  Form  10-QSB  and in other  places,  particularly,  Management's
Discussion and Analysis of Financial  Condition and Results of  Operations,  and
include statements  regarding the intent,  belief or current expectations of the
Company,  its directors or its officers with respect to, among other things: (i)
the Company's  liquidity  and capital  resources;  (ii) the Company's  financing
opportunities and plans and (iii) the Company's future performance and operating
results.  Investors  and  prospective  investors  are  cautioned  that  any such
forward-looking  statements are not guarantees of future performance and involve
risks and  uncertainties,  and that actual  results may differ  materially  from
those  projected  in the  forward-looking  statements  as a  result  of  various
factors.  The factors that might cause such differences  include,  among others,
the  following:  (i) any  material  inability  of the  Company  to  successfully
identify,  consummate  and integrate  the  acquisition  of companies  within the
global  telecommunications  industry at reasonable and anticipated  costs to the
Company;  (ii) any material inability of the Company to successfully  internally
develop  its  products;  (iii)  any  adverse  effect  or  limitations  caused by
Governmental  regulations;  (iv) any adverse  effect on the Company's  continued
positive  cash flow and abilities to obtain  acceptable  financing in connection
with its growth  plans;  (v) any  increased  competition  in business;  (vi) any
inability  of the Company to  successfully  conduct its business in new markets;
and (vii) other risks including those  identified in the Company's  filings with
the Securities and Exchange Commission.  The Company undertakes no obligation to
publicly  update or revise  the  forward  looking  statements  made in this Form
10-QSB to reflect events or circumstances  after the date of this Form 10-QSB or
to reflect the occurrence of unanticipated events.





                                       10
<PAGE>



PART II. - OTHER INFORMATION

Item 1. Legal Proceedings

      NONE

Item 2. Changes in Securities

      At a special  meeting of  stockholders  on  January 5, 2001,  the Board of
Directors of the Company and a majority of its stockholders  agreed to amend its
Articles  of  Incorporation  to increase  its  authorized  capital  stock to 500
million shares of common stock.  On January 5, 2001, the Board of Directors also
approved a stock  dividend of two and one third  shares for each share of common
stock outstanding as of the record date of January 23, 2001.

Item 3. Defaults Upon Senior Securities

      NONE

Item 4. Submission of Matters to a Vote of Securities Holders

      At a special  meeting of  stockholders  on  January 5, 2001,  stockholders
holding a  majority  of the  company's  outstanding  common  stock  approved  an
amendment to the Company's  Articles of Incorporation to increase its authorized
capital stock to 500 million shares of common stock.

Item 5. Other Information

      NONE

Item 6. Exhibits and Reports on Form 8-K

        (a)   Exhibits:

            3(i).4 Amendment to Articles of Incorporation filed January 8, 2001.


            10.1 Agreement dated January 25, 2001 between Standard Registrar &
            Transfer Company, Inc. and CDX.com, Inc.


         (b)   Form 8-K, filed November 12, 2000.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

February 20, 2001                                  /s/Phillip A. Verruto
-----------------                                  -------------------------
     Date                                          Philip A. Verruto,
                                                   Chief Executive Officer




                                       11
<PAGE>